HRAS and neoplasm: In mouse mammary tumors consisting of a Wnt1-producing, Hras wild-type luminal subclone and an Hras-mutant basal subclone, it was found that both subclones were necessary for tumor propagation, with a critical dependence on luminally produced Wnt1 [59].